LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "bimatoprost" as a keyword



Photo by tamarabellis from unsplash

Preparation of topical bimatoprost with enhanced skin infiltration and in vivo hair regrowth efficacy in androgenic alopecia

Sign Up to like & get
recommendations! Published in 2022 at "Drug Delivery"

DOI: 10.1080/10717544.2022.2027046

Abstract: Abstract To prepare a topical formulation of bimatoprost (BIM) with high skin permeability, we designed a solvent mixture system composed of ethanol, diethylene glycol monoethyl ether, cyclomethicone, and butylated hydroxyanisole, serving as a volatile solvent,… read more here.

Keywords: androgenic alopecia; hair regrowth; bim; hair ... See more keywords
Photo by schluditsch from unsplash

Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open‐label study

Sign Up to like & get
recommendations! Published in 2022 at "Dermatologic Therapy"

DOI: 10.1111/dth.15438

Abstract: Bimatoprost is a synthetic prostaglandin structural analogue used among other indications to increase eyelash growth. The aim of this prospective, open‐label study was to evaluate the safety and efficacy of topical bimatoprost in the treatment… read more here.

Keywords: prospective open; topical bimatoprost; treatment; open label ... See more keywords
Photo by jamessutton_photography from unsplash

Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis

Sign Up to like & get
recommendations! Published in 2021 at "British Journal of Ophthalmology"

DOI: 10.1136/bjophthalmol-2020-317262

Abstract: Background/aims To assess the comparative efficacy of latanoprostene bunod (LBN), a novel prostaglandin analogue (PGA), to other medications for open-angle glaucoma and ocular hypertension on lowering intraocular pressure (IOP). Methods A systematic literature review adapted… read more here.

Keywords: ophthalmology; angle glaucoma; bimatoprost; efficacy latanoprostene ... See more keywords
Photo from wikipedia

Granulomatous uveitis and choroidal detachment in a patient after topical treatment with Bimatoprost: A case report.

Sign Up to like & get
recommendations! Published in 2021 at "European journal of ophthalmology"

DOI: 10.1177/1120672121990573

Abstract: BACKGROUND Bimatoprost 0.03% is an intraocular pressure (IOP) lowering prostaglandin analog with different adverse side effects such as potential ocular inflammatory effect and ocular hyperemia. CASE PRESENTATION We report a case of 80-year-old woman diagnosed… read more here.

Keywords: uveitis choroidal; case; choroidal detachment; report ... See more keywords
Photo from wikipedia

Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma

Sign Up to like & get
recommendations! Published in 2020 at "AAPS PharmSciTech"

DOI: 10.1208/s12249-020-1622-6

Abstract: Bimatoprost is widely used for the management of glaucoma. Currently, it is delivered via eye drop solution, which is highly inefficient due to low bioavailability. To control the release of ocular drugs, contact lenses are… read more here.

Keywords: bimatoprost; contact lenses; technology; contact ... See more keywords
Photo from wikipedia

Bimatoprost-Loaded Silica Shell-Coated Nanoparticles-Laden Soft Contact Lenses to Manage Glaucoma: In Vitro and In Vivo Studies.

Sign Up to like & get
recommendations! Published in 2021 at "AAPS PharmSciTech"

DOI: 10.1208/s12249-021-02199-0

Abstract: Currently, glaucoma is managed by frequent instillation of bimatoprost eye drop therapy, which showed very poor ocular bioavailability. Contact lens is widely used as medical device to improve the drug retention on the ocular tissues.… read more here.

Keywords: bimatoprost; contact; contact lens; silica shell ... See more keywords
Photo by paipai90 from unsplash

Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study

Sign Up to like & get
recommendations! Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms232214113

Abstract: Prostaglandin analogues (PGAs), including bimatoprost (BIM), are generally the first-line therapy for glaucoma due to their greater efficacy, safety, and convenience of use. Commercial solutions of preservative-free BIM (BIM 0.03% and 0.01%) are already available,… read more here.

Keywords: human conjunctival; bim; preservative free; exposure ... See more keywords